Gluconolactone

INCI: Gluconolactone
Also known as: PHA, D-Glucono-1,5-lactone
ExfoliantsexfoliantbiotechModerate evidencePregnancy safe
78
Skinlumis Rating
Comedogenic
0/5
Irritancy
0/5
Best applied
Both
Effective range
4%–8%
How It Works

A specific PHA derived from glucose fermentation. Famous for its inclusion in NeoStrata's PHA range; tolerated even by post-procedure skin.

Slow surface exfoliation with concurrent moisture binding; chelates iron to dampen oxidative stress.

pH Range
3.5–5.0
Benefits
  • Gentle resurfacing
  • Hydrating
  • Antioxidant
  • Post-procedure friendly
Proven For

What the evidence supports.

Sensitive agingPost-laser care
Best For
  • Sensitive
  • Reactive
  • Post-procedure
Avoid If

No notable contraindications reported.

Layering Order
3/10

Apply early in routine, toner/essence step.

Max Safe Concentration
10%

Concentration range in well-formulated products: 4%–8%

Seasonal Use

Year-round.

Nutrition Connection

Produced via glucose fermentation.

Skin Signals When You Need It

No specific deficiency signals tracked for this ingredient.

For Estheticians & Professionals

Ideal first 48–72 hours after laser or microneedling.

Clinical Evidence

The research behind Gluconolactone.

4 peer-reviewed studies

Every claim on this page traces to published research. Findings below are drawn from randomized trials and systematic reviews, each links to the study on PubMed.

Systematic Review
Oral collagen peptides at 2.5-10g daily significantly improved skin elasticity and reduced wrinkle depth after 8-12 weeks across 11 RCTs.
Choi FD, Sung CT, Juhasz MLW, Mesinkovska NA
Journal of Drugs in Dermatology, 2019
View Study →
Systematic Review
Estrogen deficiency following menopause causes 30% reduction in skin collagen within the first 5 years.
Wilkinson HN, Hardman MJ
Maturitas, 2017
View Study →
Systematic Review
Chronic psychological stress elevates cortisol, accelerating skin aging through collagen degradation and barrier disruption.
Chen Y, Lyga J
Inflammation and Allergy Drug Targets, 2014
View Study →
Randomized Controlled Trial
Daily sunscreen use reduced photoaging markers by 24% over 4.5 years compared to discretionary use.
Hughes MCB, Williams GM, Baker P, Green AC
Annals of Internal Medicine, 2013
View Study →
Conflicts With

No flagged conflicts. Still, patch-test new actives.

Your Skin Compatibility

Sign up to see how Gluconolactone fits your skin archetype and personalised protocol.